The global female external catheter market size is likely to be valued at US$2.4 billion in 2026 and is estimated to reach US$3.7 billion by 2033, growing at a CAGR of 6.7% during the forecast period from 2026 to 2033, driven by the rising focus on reducing Catheter-Associated Urinary Tract Infections (CAUTIs) and increasing prevalence of urinary incontinence among the aging female population.

Emergence of silicone-based and adhesive-free catheter designs is also pushing market growth.

Driver - Increasing Need to Lower Infection Rates from Indwelling Catheters

Catheter-Associated Urinary Tract Infections (CAUTIs) are one of the most common and costly healthcare-associated infections. According to the U.S. Centers for Disease Control and Prevention (CDC), in 2023, acute care hospitals reported more than 17,000 CAUTI events occurring over 23 million urinary catheter device-days. Approximately 12% to 16% of adult hospital inpatients had an indwelling catheter at some point during their admission.

Female External Catheters (FECs) address this by eliminating the need for bladder instrumentation. A peer-reviewed study published in Cureus (2020) at Thomas Jefferson University confirmed that after introducing FECs in intensive care units, CAUTI rates decreased from 3.14 to 1.42 per 1,000 catheter days. It is a statistically significant reduction, while total ICU patient days increased. A quality improvement study published in Open Forum Infectious Diseases (2025) from Allegheny General Hospital confirmed a similar result. CAUTI rates fell significantly after external urethral catheters were introduced for both female and male patients across intensive care units.

Surging Demand for Non-Invasive Catheters to Move Freely

Inserting an indwelling catheter requires trained clinical staff, carries a risk of urethral injury, and tethers the patient to a drainage bag. It restricts movement and requires careful repositioning. Female external catheters eliminate many of these constraints. They sit outside the body, require no insertion, and can be placed by a nurse without specialist training. A nurse-led intervention study published in the American Nurse Journal (February 2026) confirmed that promoting FEC use not only minimized infection risk but also increased patient and nurse satisfaction by enabling urine output monitoring and enhancing patient dignity.

The real-world impact on patient dignity and skin health was confirmed in a six-month evaluation conducted by University Hospitals of Leicester NHS Trust, published by NHS Supply Chain in December 2025. Of 45 female patients who used a female external catheter during the evaluation period, none developed Incontinence-Associated Dermatitis (IAD), compared to 43 cases of IAD in 798 female patients during the previous six-month baseline period, representing a 93% reduction.

Restraint - Frequent Leaking Issues May Hinder Adoption

Female external catheters work by resting against the perineal anatomy and wicking or suctioning urine away through a tube. They do not use adhesive to create a watertight seal around the body. This means that patient movement can displace the device and allow urine to bypass it. According to a systematic review and meta-analysis of female external urine wicking devices published in Infection Control & Hospital Epidemiology (2024) by researchers from the U.S. Department of Veterans Affairs, two randomized controlled trials evaluating PureWick were still ongoing at the time of publication.

There is no completed randomized evidence yet available on urine capture rate under real-world movement conditions. This shows that the leakage problem under dynamic conditions remains incompletely characterized. Market analysis confirmed this. Achieving a consistent, leak-proof seal is more complex in female external catheters than in male equivalents, which can lead to product dissatisfaction and reluctance to use among patients and healthcare providers. Until designs can reliably maintain performance across a range of body shapes and positions, leakage will likely continue to limit adoption in active or high-acuity patients.

Opportunity - Launch of Low-Pressure Suction Systems

Rather than relying on passive absorption, modern Female External Catheters (FECs) use continuous gentle suction to actively pull urine away from the body the moment voiding begins. According to BD's official product information for the PureWick Flex Female External Catheter, the device uses low-pressure wall suction and bendable tubing to maximize comfort and positioning while maintaining high urine capture efficiency. The flexible and breathable fabric wick draws urine away from the skin to support dryness.

A randomized trial published in PMC (2025) found that the PureWick system provided better outcomes on patient-reported measures of comfort, dryness, and sleep quality. The study confirmed that absorbent products such as pads are associated with stigma and complications and require frequent changes that lead to sleep disruptions, reduced comfort, and increased risk of falls. This makes active suction-based FECs the preferred alternative for overnight incontinence management. This active suction principle is now being incorporated into portable home-use collection systems, expanding the FEC category from hospital-only use to a home-care product.

Growing Use of Advanced Skin-Friendly Materials

The clinical risk that makes effective FEC design so important is Incontinence-Associated Dermatitis (IAD), i.e., skin damage caused by prolonged contact with urine. Conventional absorptive pads trap moisture against the skin. FECs using advanced wicking fabrics actively move it away. BD's PureWick Flex platform specifically addresses this through a multi-layer fabric architecture. According to the firm, the PureWick Flex Female External Catheter features a soft, multi-layered flexible fabric designed to draw urine away from the body. It has an advanced multi-layer wick that helps keep skin dry and reduces the risk of incontinence-associated dermatitis.

A quality improvement study published in the Journal of Clinical Nursing (2025) conducted across multiple acute care sites confirmed that external female urinary catheters are a non-invasive alternative strategy to reduce exposure of regional skin to urine contamination and IAD-related skin complications. Patients who used the device exhibited significantly lower rates of skin breakdown compared to those managed with standard incontinence pads. As materials science continues to improve moisture transport and skin compatibility, FECs using advanced multi-layer fabrics are being adopted as the first-line non-invasive skin protection strategy in hospital and long-term care settings.

Product Type Insights

Disposable female external catheters are predicted to lead with a share of approximately 45.6% in 2026, as they significantly reduce the risk of cross-contamination and healthcare-associated infections. Hospitals and intensive care units prefer single-use devices as they comply with infection-prevention protocols and eliminate the need for cleaning or sterilization. Since female external catheters are often used for critically ill, post-operative, and elderly patients, clinicians prioritize products that ensure hygiene and consistent performance.

Non-adhesive catheters are estimated to be the fastest-growing segment over the forecast period, as they offer greater patient comfort and reduce the likelihood of skin damage. Female patients, especially older adults and those with fragile skin, are prone to skin irritation from adhesives. Hence, several manufacturers have introduced suction-based or anatomically designed non-adhesive systems that remain in position without requiring direct skin adhesion.

Material Insights

The silicone segment is anticipated to dominate with a share of nearly 42.3% in 2026 as it is highly biocompatible, soft, and suitable for prolonged skin contact. It minimizes allergic reactions, resists bacterial growth better than multiple conventional materials, and provides flexibility that improves patient comfort. These characteristics make silicone the preferred choice for female external catheters used in hospitals, rehabilitation centers, and home healthcare.

The polyurethane segment is expected to remain in the second position in 2026, owing to its excellent flexibility, durability, and moisture resistance. It provides a soft interface with the skin while maintaining structural strength, making it suitable for external urinary collection devices that require reliable urine flow and prolonged wear. Manufacturers now use polyurethane in advanced urinary management products as it can be combined with breathable and skin-friendly designs.

North America Female External Catheter Market Trends

North America is predicted to dominate globally in 2026, with a share of approximately 47.6%, as hospitals in the region have adopted non-invasive urinary management devices to reduce CAUTIs. The U.S. Centers for Disease Control and Prevention (CDC) reports that about 75% of hospital-acquired UTIs are associated with urinary catheters, which encourages healthcare providers to minimize the use of indwelling catheters whenever possible. This has increased the preference for female external catheters in acute care and critical care settings.

U.S. Female External Catheter Market Trends

A regional share of nearly 70.6% is expected to be held by the U.S. in 2026 in North America, as healthcare providers are prioritizing infection prevention and reducing unnecessary Foley catheter use. The CDC continues to recommend limiting the duration of indwelling catheterization and evaluating alternatives whenever appropriate. Hospitals are therefore investing in external urinary management systems for females that can reduce infection risk while improving patient comfort.

Asia Pacific Female External Catheter Market Trends

Asia Pacific is anticipated to be the fastest-growing region globally in 2026, with a share of nearly 30.2%, as healthcare infrastructure continues to improve and the elderly population grows across key economies. Governments are expanding hospital capacity, long-term care services, and infection control programs, creating favorable conditions for advanced urinary management products. The region is also witnessing rising awareness of hospital-acquired infections and pressure injury prevention. Several tertiary hospitals are adopting international infection-control practices, prompting clinicians to consider external urinary devices rather than prolonged indwelling catheterization when clinically appropriate.

China Female External Catheter Market Trends

China will likely lead Asia Pacific in 2026, with a regional share of around 33.5%, benefiting from ongoing investments in hospital modernization and critical care services. The country is expanding intensive care capacity while strengthening infection prevention measures, further driving demand for technologies that improve patient safety. Female external catheters align well with these objectives, as they provide non-invasive urinary management.

India Female External Catheter Market Trends

In 2026, India is projected to account for approximately 14.2% of the Asia Pacific regional share, as hospitals today focus on reducing healthcare-associated infections and improving nursing efficiency. Large multispecialty hospitals are adopting evidence-based infection control protocols, encouraging the use of non-invasive urinary management solutions for appropriate patients instead of prolonged indwelling catheterization.

Europe Female External Catheter Market Trends

Europe will likely witness steady growth over the forecast period, with a global share of nearly 13.9% in 2026, as healthcare institutions place strong emphasis on patient safety, infection prevention, and evidence-based clinical practice. Hospitals across the region continue to implement protocols aimed at reducing unnecessary urinary catheterization and preventing CAUTIs. These policies support the gradual adoption of female external catheters in intensive care, rehabilitation, and long-term care facilities.

Germany Female External Catheter Market Trends

Germany will likely register a substantial regional share of approximately 39.4% in 2026 in Europe, backed by its advanced hospital infrastructure and high standards for infection control. Hospitals routinely invest in technologies that improve nursing workflows and patient outcomes, creating favorable conditions for the adoption of external catheters for females. The country also has a large elderly population requiring rehabilitation and long-term care. Demand is supported by Germany's well-developed medical technology sector and reimbursement environment, which encourages hospitals to adopt clinically validated devices.

U.K. Female External Catheter Market Trends

A regional share of around 27.3% is predicted to be held by the U.K. in 2026 in 2026, as the healthcare network continues to prioritize reducing hospital-acquired infections and improving patient experience. Hospitals are placing greater emphasis on avoiding unnecessary indwelling catheter use, especially among elderly and immobile patients, which supports the use of external urinary management devices. Demand is also likely to benefit from rising home-based care and community healthcare services.

The global female external catheter market is moderately consolidated, with competition led by a small group of specialized urinary care and medical device companies. Leading companies include BD, Stryker, Coloplast, Hollister, Medline Industries, Consure Medical, TillaCare, Boehringer Laboratories, and Ur24Technology. They are focusing on anatomical design improvements that better fit female anatomy, minimize urine leakage, and reduce skin breakdown.

As female external catheters are technically more challenging than male devices, manufacturers are differentiating themselves through proprietary suction mechanisms, soft silicone or hydrocolloid interfaces, moisture management, and compatibility with hospital vacuum systems rather than simply expanding product portfolios. Innovation has become the primary competitive strategy. Companies are investing in adhesive-free designs, breathable materials, antimicrobial coatings, and devices intended to lower the risk of Catheter-Associated Urinary Tract Infections (CAUTIs).

Key Industry Developments:

• In April 2026, BD announced new clinical evidence supporting the PureWick Urine Collection System following publication of the randomized trial in the Journal of Clinical Medicine. The company reported that women using the PureWick Flex Female External Catheter experienced improved sleep quality, easy device placement and removal, and greater comfort during nighttime urinary incontinence management.
• In January 2026, Wellspect HealthCare, a subsidiary of Dentsply Sirona, announced the U.S. launch of the Surity Female External Catheter, a new non-invasive solution for women living with severe urinary incontinence. The launch marked Wellspect's entry into the female external catheter category, expanding beyond its established LoFric intermittent catheter and Navina bowel management brands.
• In February 2025, researchers at Allegheny General Hospital, Allegheny Health Network, Pittsburgh, published a quality improvement study in Open Forum Infectious Diseases examining the impact of external urethral catheter use on Catheter-Associated Urinary Tract Infections (CAUTIs) in intensive care units. The study found that among 132 female CAUTI cases examined, introducing external urethral catheters resulted in a relative risk reduction of 61% post-implementation, compared to a 33% reduction in male cases.